Bin Ma

Design, synthesis and identification of novel, orally bioavailable non-covalent Nrf2 activators

Bin Ma, Brian S. Lucas, Andrew G. Capacci et al. · Bioorganic & Medicinal Chemistry Letters · 2019 · 42 citations · Full text

Medicine, Chemistry, Pharmacology +3

ATP-Competitive MLKL Binders Have No Functional Impact on Necroptosis

Bin Ma, Doug Marcotte, Murugan Paramasivam et al. · PLoS ONE · 2016 · 37 citations · Full text

Mitophagy, Apoptosis, Cell Death +16

Discovery of BIIB068: A Selective, Potent, Reversible Bruton’s Tyrosine Kinase Inhibitor as an Orally Efficacious Agent for Autoimmune Diseases

Bin Ma, Tonika Bohnert, Kevin L. Otipoby et al. · Journal of Medicinal Chemistry · 2020 · 36 citations · Full text

Discovery and Preclinical Characterization of BIIB091, a Reversible, Selective BTK Inhibitor for the Treatment of Multiple Sclerosis

Brian T. Hopkins, Eris Bame, Bekim Bajrami et al. · Journal of Medicinal Chemistry · 2021 · 36 citations · Full text

Immunology, Neurological Progress, Immunotherapy +16

A modified Curtius reaction: an efficient and simple method for direct isolation of free amine

Bin Ma, Wen‐Cherng Lee · Tetrahedron Letters · 2009 · 24 citations

Chemical Engineering, Novel Organocatalysts, Engineering +7